| 视网膜母细胞瘤诊断和治疗的研究进展 |
| |
| 引用本文： | 崔雪皓,李筱荣. 视网膜母细胞瘤诊断和治疗的研究进展[J]. 眼科新进展, 2022, 0(8): 634-638. DOI: 10.13389/j.cnki.rao.2022.0130 |
| |
| 作者姓名： | 崔雪皓 李筱荣 |
| |
| 作者单位： | 300383 天津市，天津医科大学眼科医院、眼视光学院、眼科研究所，天津市视网膜功能与疾病重点实验室，天津市眼科学与视觉科学国际联合研究中心 |
| |
| 基金项目： | 国家自然科学基金(面上项目)(编号：82171085)； |
| |
| 摘 要： | 视网膜母细胞瘤(RB)是儿童最常见的眼内恶性肿瘤，常严重影响患儿的视功能、生活质量甚至生命安全。随着医学技术的不断发展，RB的诊断与治疗取得许多新的突破，有效地提高了RB患儿的保眼率及生存率。除了传统的影像学、眼科特检等检查外，基因诊断近些年来在临床上广泛开展。本文将重点对RB的诊断及治疗的新进展进行综述。
|
| 关 键 词： | 视网膜母细胞瘤 基因诊断 基因治疗 化学治疗 |
Advances in diagnosis and treatment of retinoblastoma |
| |
| CUI Xuehao,LI Xiaorong. Advances in diagnosis and treatment of retinoblastoma[J]. Recent Advances in Ophthalmology, 2022, 0(8): 634-638. DOI: 10.13389/j.cnki.rao.2022.0130 |
| |
| Authors: | CUI Xuehao LI Xiaorong |
| |
| Affiliation: | Tianjin Key Laboratory of Retinal Functions and Diseases,Tianjin International Joint Research and Development Centre of Ophthalmology and Vision Science,Eye Institute and School of Optometry,Tianjin Medical University Eye Hospital,Tianjin 300383,China |
| |
| Abstract: | Retinoblastoma (RB) is the most common intraocular malignant tumor in childhood, which seriously affects the visual function, quality of life, and even life safety of patients. With the continuous development of medical technology, many breakthroughs have been made in the diagnosis and treatment of RB to effectively improve the eye protection rate and survival rate of children with RB in recent years. In addition to traditional imaging and ophthalmologic examinations, gene diagnosis has been widely used in clinical practices. This article reviews the new advances in the diagnosis and treatment of RB. |
| |
| Keywords: | retinoblastoma gene diagnosis gene therapy chemotherapy |
|
| 点击此处可从《眼科新进展》浏览原始摘要信息 |
|
点击此处可从《眼科新进展》下载免费的PDF全文 |
